Registration Links (4 Options)
Speakers Reg Patient Reg Reg for Clinical Trials Community Network
Logo

Cancer Facts & Epidemiological Statistics

Comprehensive clinical data, global incidence benchmarks, survival rate statistics, and modern epidemiological trends.

General Facts & Overview

Cancer remains one of the leading causes of morbidity and mortality worldwide. However, advances in precision genomics, biomarker-driven clinical trials, and early population screening have yielded significant improvements in overall 5-year survival rates over the past three decades.

  • Over 100 distinct histological cancer types have been classified, with solid epithelial carcinomas comprising the large majority.
  • Approximately 1 in 2 men and 1 in 3 women will be diagnosed with an invasive cancer during their lifetime.
  • The overall 5-year relative cancer survival rate has risen from 49% in the 1970s to over 68% today across all combined cancer sites.

Global & United States Incidence & Mortality Data

  • Global Incidence: Over 20 million new cancer cases are diagnosed annually worldwide, resulting in approximately 9.7 to 10 million deaths.
  • U.S. Annual Burden: Approximately 2.0 million new cancer diagnoses and ~610,000 cancer-related deaths per year.
  • Leading Causes of Cancer Mortality: Lung and bronchus cancer accounts for the highest mortality burden, followed by colorectal, pancreatic, breast, and prostate cancers.

Top Most Common Cancers & 5-Year Survival Benchmarks

Cancer Type Estimated Annual New Cases 5-Year Relative Survival Rate Key Prognostic Determinants
Breast Cancer (Female) ~310,000 ~91% (Overall) / >99% (Localized) ER/PR/HER2 receptor status, Oncotype DX score, lymph node staging
Prostate Cancer ~299,000 ~97% (Overall) / >99% (Local/Regional) PSA velocity, Gleason score, genomic decipher risk score
Lung & Bronchus Cancer ~234,000 ~25% (Overall) / ~63% (Localized) Histology (NSCLC vs SCLC), EGFR/ALK/KRAS driver mutations, PD-L1
Colorectal Cancer ~152,000 ~65% (Overall) / ~91% (Localized) MSI/MMR status, KRAS/NRAS/BRAF mutations, stage at colonoscopy
Melanoma (Skin) ~100,000 ~94% (Overall) / >99% (Localized) Breslow tumor thickness, ulceration status, BRAF V600E mutation

Key Epidemiological Trends

Progress in modern oncology is driven by 3 primary pillars: population-wide tobacco reduction, widespread screening compliance (mammograms, colonoscopies, Pap/HPV tests), and biomarker-matched targeted/immunotherapies.
  • Declining cigarette smoking rates have driven a steady drop in lung cancer incidence and mortality over the last 25 years.
  • Widespread adoption of HPV vaccination is drastically cutting cervical cancer rates among vaccinated cohorts.
  • Increased emphasis is now placed on curbing rising rates of early-onset colorectal cancer through lowered screening age recommendations (starting at age 45).

Contact Support
Counselor Logo
ONCORG Care Counselor
Online | 24/7 Support
Today
Hello! 👋 Welcome to ONCORG Cancer Support. We are here to help you navigate treatment options, clinical trials, and patient resources.
How can we assist you today? Select a quick topic below or type your question: